Allergan Partners with Assembly Bio to Gain Microbiome Gastrointestinal Development Programmes
By Natasha Piper
Pharma Deals Review: Vol 2017 Issue 3 (Table of Contents)
Published: 9 Mar-2017
DOI: 10.3833/pdr.v2017.i3.2230 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
In an effort to expand its gastroenterology therapeutic presence, Allergan has entered into a collaboration and licence agreement with Assembly Biosciences for the global rights to the latter’s microbiome gastrointestinal development programmes for a total deal value of up to US$2...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS